Sign in to continue:

Saturday, March 21st, 2026

AcroMeta Group Receives SGX Approval for Employee Share Option Scheme 2026 Share Listing

Key Points for Investors

  • Approval Received: AcroMeta Group Limited announced that it has received the Listing and Quotation Notice (LQN) from the Singapore Exchange Securities Trading Limited (SGX-ST) for the new ordinary shares to be issued under its Employee Share Option Scheme 2026 (ESOS 2026).
  • Scheme Details: The ESOS 2026 was approved by shareholders on 23 January 2026. The new shares will be issued and allotted when employees exercise their options under this scheme.
  • Compliance: The listing approval is subject to AcroMeta’s compliance with SGX-ST’s listing requirements.
  • Merits Not Endorsed: The LQN from SGX-ST should not be interpreted as an endorsement of the merits of ESOS 2026, the new shares, or the company.
  • Future Announcements: AcroMeta will make further announcements regarding any material developments, including the granting of share options/awards and the issuance and allotment of new shares.

Potential Share Price Impact & Shareholder Information

  • Price Sensitivity: The implementation of ESOS 2026 could have direct effects on share price. Issuance of new shares may dilute existing holdings, but it also aligns employee interests with shareholders and can incentivize performance.
  • Shareholder Rights: Shareholders should note that the scheme was approved by them and is now moving forward, with formal SGX approval for listing the new shares.
  • Ongoing Disclosure: Investors should monitor company announcements for further details on option grants, awards, and share issuance, as these events can affect the total share capital and potentially the share price.
  • Regulatory Oversight: The announcement is reviewed by AcroMeta’s Sponsor, W Capital Markets Pte. Ltd., but not by SGX-ST itself. The exchange explicitly assumes no responsibility for the contents.
  • Contact Information: For queries regarding the sponsorship, investors can contact Mr. Brian Ching at W Capital Markets, OCBC Centre, Singapore.

Summary for Investors

The receipt of SGX’s LQN for ESOS 2026 marks a significant step in AcroMeta Group’s capital and incentive planning. Shareholders and investors should be aware of the potential dilution from new shares issued under the scheme, but also recognize its role in motivating employees and aligning interests. All material developments, including option grants and share issuances, will be disclosed by the company. These could impact the share price and investor sentiment depending on the scale and timing of such actions.

Disclaimer

This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own research and consult with financial advisors before making any investment decisions. The Singapore Exchange Securities Trading Limited assumes no responsibility for the accuracy or completeness of the information presented here.

View 龙净环保 Historical chart here



福建龙净环保2025年度利润分配方案公告:每股派发现金红利0.38元,分红比例达43.39%

福建龙净环保2025年度利润分配方案详细解读 福建龙净环保发布2025年度利润分配方案,现金分红大幅提升,投资者需重...

Zhejiang Pharmaceutical (600216) Major Shareholder Announces Up to 1% Share Reduction Plan via Centralized Bidding

浙江医药股份有限公司大股东减持公告深度解读 浙江医药股份有限公司大股东减持计划公告深度解读 一、公告要点概述 大股...

中航重机部分董事及高管增持股份进展公告(2026年3月)

中航重机部分董事及高管增持股份计划进展公告详解 中航重机部分董事及高管增持股份计划进展公告详解 一、公告重点摘要 ...

   Ad